Treatment with supplemental oxygen during a heart attack

Phase 1

• Conditions: Acute myocardial infarction; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2013-002882-20-SE
• Lead Sponsor: Västra Götalands Center för utveckling av prehospital akutsjukvård

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-27
• Last Update Posted: 12 March 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 6600

Inclusion Criteria

Patients = 30 years of age with normal oxygen saturation (=90% on pulse oximeter) presenting to the ambulance service or the emergency department (ED) with classical symptoms suggestive of acute coronary syndrome (ACS) within the last 6 hours and significant ECG changes (characterized by ST-segment elevation = 0,2 mV V1-V4, or = 0.1 mV in other leads, ST-segment depression =0.1 mV in any lead, negative ischemic T-wave in leads V2-V6, pathological Q-wave in at least 2 adjacent leads, or left bundle branch block) or elevated cardiac biomarkers
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 2640
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 3960

Exclusion Criteria

Hypoxia (oxygen saturation <90%), do not consent. Treatment with continuous oxygen therapy. Cardiac arrest prior to inclusion

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified